| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014429 |
| Receipt No. | R000016794 |
| Scientific Title | Investigation for Association of Adiponectin and Acute Coronary Syndrome |
| Date of disclosure of the study information | 2020/01/01 |
| Last modified on | 2020/01/14 (Ver. 3) |
| Basic information | ||
| Public title | Investigation for Association of Adiponectin and Acute Coronary Syndrome | |
| Acronym | i4ACS | |
| Scientific Title | Investigation for Association of Adiponectin and Acute Coronary Syndrome | |
| Scientific Title:Acronym | i4ACS | |
| Region |
|
|
| Condition | |||
| Condition | Acute myocardial infarction, Angina pectoris | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify the significance of circulating factors relating to life style-associated diseases. |
| Basic objectives2 | Others |
| Basic objectives -Others | To clarify the difference of concentrations in circulating factors in coronary and aortic blood |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Significance of circulating factors relating to life style-associated diseases. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects who were diagnosed as acute myocardial infection or angina pectoris, and then treated by PCI. Subjects agreed with study protocol. | |||
| Key exclusion criteria | (1) Cases with significant stenosis in the left main trunk (LMT) or with post-CABG or with post-intracoronary stenting or with pioglitazone treatment.
(2) Subjects who were judged inadequate for the study by the attending physician. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, Osaka University | ||||||
| Division name | Department of Metabolic Medicine | ||||||
| Zip code | |||||||
| Address | 2-2-B5, Yamada-oka, Suita, Osaka, Japan | ||||||
| TEL | 06-6879-3737 | ||||||
| ichi@endmet.med.osaka-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, Osaka University | ||||||
| Division name | Department of Metabolic Medicine | ||||||
| Zip code | |||||||
| Address | 2-2-B5, Yamada-oka, Suita, Osaka, Japan | ||||||
| TEL | 06-6879-3737 | ||||||
| Homepage URL | |||||||
| norikazu_maeda@endmet.med.osaka-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Metabolic Medicine,
Graduate School of Medicine, Osaka University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Metabolic Medicine,
Graduate School of Medicine, Osaka University |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Measurement of adipocytokines, oxidative stresses, and factors relating to atherosclerosis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016794 |